Geode Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $478M | Buy |
9,435,132
+215,488
| +2% | +$10.1M | 0.03% | 453 |
|
|
2025
Q4 | $271M | Sell |
9,219,644
-29,708
| -0.3% | -$807K | 0.02% | 617 |
|
|
2025
Q3 | $238M | Buy |
9,249,352
+372,072
| +4% | +$10.4M | 0.02% | 646 |
|
|
2025
Q2 | $244M | Buy |
8,877,280
+1,420,690
| +19% | +$37.4M | 0.02% | 601 |
|
|
2025
Q1 | $211M | Buy |
7,456,590
+215,236
| +3% | +$7.64M | 0.02% | 621 |
|
|
2024
Q4 | $300M | Buy |
7,241,354
+171,774
| +2% | +$8.21M | 0.02% | 516 |
|
|
2024
Q3 | $471M | Buy |
7,069,580
+178,115
| +3% | +$16.4M | 0.04% | 389 |
|
|
2024
Q2 | $816M | Buy |
6,891,465
+140,986
| +2% | +$17.8M | 0.07% | 247 |
|
|
2024
Q1 | $718M | Buy |
6,750,479
+201,018
| +3% | +$20.3M | 0.07% | 275 |
|
|
2023
Q4 | $649M | Buy |
6,549,461
+134,452
| +2% | +$11.3M | 0.07% | 274 |
|
|
2023
Q3 | $661M | Buy |
6,415,009
+112,512
| +2% | +$12.6M | 0.08% | 241 |
|
|
2023
Q2 | $764M | Buy |
6,302,497
+57,540
| +0.9% | +$7.68M | 0.09% | 213 |
|
|
2023
Q1 | $957M | Buy |
6,244,957
+77,265
| +1% | +$12.7M | 0.12% | 147 |
|
|
2022
Q4 | $1.11B | Sell |
6,167,692
-80,119
| -1% | -$13.1M | 0.16% | 122 |
|
|
2022
Q3 | $738M | Sell |
6,247,811
-89,880
| -1% | -$13.6M | 0.11% | 169 |
|
|
2022
Q2 | $904M | Sell |
6,337,691
-98,663
| -2% | -$14.1M | 0.13% | 139 |
|
|
2022
Q1 | $1.11B | Buy |
6,436,354
+403,891
| +7% | +$68M | 0.14% | 128 |
|
|
2021
Q4 | $1.53B | Buy |
6,032,463
+272,502
| +5% | +$79.7M | 0.18% | 93 |
|
|
2021
Q3 | $2.21B | Buy |
5,759,961
+2,404,103
| +72% | +$887M | 0.3% | 59 |
|
|
2021
Q2 | $787M | Sell |
3,355,858
-450,572
| -12% | -$80.5M | 0.11% | 162 |
|
|
2021
Q1 | $498M | Buy |
3,806,430
+235,190
| +7% | +$34.1M | 0.08% | 258 |
|
|
2020
Q4 | $373M | Buy |
3,571,240
+206,455
| +6% | +$20.9M | 0.06% | 300 |
|
|
2020
Q3 | $238M | Buy |
3,364,785
+36,749
| +1% | +$2.56M | 0.05% | 356 |
|
|
2020
Q2 | $214M | Buy |
3,328,036
+674,217
| +25% | +$36.9M | 0.05% | 368 |
|
|
2020
Q1 | $79.5M | Buy |
2,653,819
+320,551
| +14% | +$7.37M | 0.02% | 573 |
|
|
2019
Q4 | $45.6M | Buy |
2,333,268
+99,167
| +4% | +$1.76M | 0.01% | 1007 |
|
|
2019
Q3 | $35.6M | Buy |
2,234,101
+1,942,210
| +665% | +$28.7M | 0.01% | 1087 |
|
|
2019
Q2 | $4.27M | Buy |
291,891
+11,755
| +4% | +$252K | ﹤0.01% | 2499 |
|
|
2019
Q1 | $5.7M | Buy |
280,136
+77,644
| +38% | +$1.44M | ﹤0.01% | 2257 |
|
|
2018
Q4 | $3.09M | Buy |
+202,492
| New | +$3.33M | ﹤0.01% | 2513 |
|
Other funds holding MRNA
VCM
VPM
TP